Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proceedings of the 9th International Symposium on MDS and SAA in Childhood : Athens, Greece. 30 September-2 October 2021. | Mol Cell Pediatr | 2021 | 34633564 | PubTator, text mining | PubMed |
| Pioneer factors in development and cancer. | iScience | 2021 | 34632331 | PubTator, text mining | PubMed |
| Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. | Cancer Cell Int | 2021 | 34627254 | PubTator, text mining | PubMed |
| Outcomes of patients with Down syndrome and acute leukemia: A retrospective observational study. | Medicine (Baltimore) | 2021 | 34622870 | PubTator, text mining | PubMed |
| p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia. | JCI Insight | 2021 | 34622806 | PubTator, text mining | PubMed |
| A Narrative Review of Circular RNAs in Brain Development and Diseases of Preterm Infants. | Front Pediatr | 2021 | 34621711 | PubTator, text mining | PubMed |
| Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2021 | 34596937 | PubTator, text mining | PubMed |
| Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases. | Front Oncol | 2021 | 34589432 | PubTator, text mining | PubMed |
| High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia. | Front Oncol | 2021 | 34589425 | PubTator, text mining | PubMed |
| 5q Deletion Myelodysplastic Syndrome in a Young Male Patient. | Cureus | 2021 | 34589360 | PubTator, text mining | PubMed |
| An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. | Bone Marrow Transplant | 2021 | 34584240 | PubTator, text mining | PubMed |
| Significance of NPM1 Gene Mutations in AML. | Int J Mol Sci | 2021 | 34576201 | PubTator, text mining | PubMed |
| Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells. | Int J Mol Sci | 2021 | 34575830 | PubTator, text mining | PubMed |
| Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution. | Genes (Basel) | 2021 | 34573358 | PubTator, text mining | PubMed |
| Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges. | Cancers (Basel) | 2021 | 34572809 | PubTator, text mining | PubMed |
| Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019. | Cancers (Basel) | 2021 | 34572762 | PubTator, text mining | PubMed |
| Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. | Blood Adv | 2021 | 34570179 | PubTator, text mining | PubMed |
| Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples. | Metabolites | 2021 | 34564403 | PubTator, text mining | PubMed |
| The heat shock response and small molecule regulators. | Eur J Med Chem | 2021 | 34563965 | PubTator, text mining | PubMed |
| Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia. | F1000Res | 2021 | 34557292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=52